| Literature DB >> 10648568 |
M Evangelista1, B M Klebl, A H Tong, B A Webb, T Leeuw, E Leberer, M Whiteway, D Y Thomas, C Boone.
Abstract
Type I myosins are highly conserved actin-based molecular motors that localize to the actin-rich cortex and participate in motility functions such as endocytosis, polarized morphogenesis, and cell migration. The COOH-terminal tail of yeast myosin-I proteins, Myo3p and Myo5p, contains an Src homology domain 3 (SH3) followed by an acidic domain. The myosin-I SH3 domain interacted with both Bee1p and Vrp1p, yeast homologues of human WASP and WIP, adapter proteins that link actin assembly and signaling molecules. The myosin-I acidic domain interacted with Arp2/3 complex subunits, Arc40p and Arc19p, and showed both sequence similarity and genetic redundancy with the COOH-terminal acidic domain of Bee1p (Las17p), which controls Arp2/3-mediated actin nucleation. These findings suggest that myosin-I proteins may participate in a diverse set of motility functions through a role in actin assembly.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10648568 PMCID: PMC2174279 DOI: 10.1083/jcb.148.2.353
Source DB: PubMed Journal: J Cell Biol ISSN: 0021-9525 Impact factor: 10.539
Figure 1The COOH-terminal acidic domain of yeast myosin-I shares sequence similarity with the COOH-terminal acidic domains of yeast Bee1p and human WASP. The oval represents the head domain of myosin-I, the circle represents the SH3 domain, and the arrow represents the acidic domain.
Two-Hybrid Interactions between the Arp2/3 Subunits, Arc19p and Arc40p, and the COOH-terminal Tails of Myo3p, Myo5p, and Bee1p
| DNA-binding domain fusion | Activation-domain fusion | LacZ expression(Miller units) |
|---|---|---|
| Arc19p | Vector | 3.4 ± 0.1 |
| Myo3p-SH3-AD | 152 ± 8 | |
| Myo5p-SH3-AD | 133 ± 16 | |
| Arc40p | Vector | 0.3 ± 0.1 |
| Myo3p-SH3-AD | 458 ± 19 | |
| Myo5p-SH3-AD | 347 ± 4 | |
| Bee1p-WH2-AD | 18 ± 1 | |
| Myo3p-SH3 | 1.8 ± 0.2 | |
| Myo3p-AD | 151 ± 15 | |
| Myo3p-ADΔW | 0.3 ± 0.1 | |
| Myo3p-AD-32 | 25 ± 1 | |
| Myo3p(SH3-W1157S)-AD | 366 ± 15 |
Assays were done as described (see Materials and Methods); pJG4-5 was the vector control.
Two-Hybrid Interactions between Bee1p, Vrp1p, and the COOH-terminal tails of Myo3p and Myo5p
| DNA-binding domain fusion | Activation-domain fusion | LacZ expression(Miller units) |
|---|---|---|
| Bee1p (1-633) | Vector | 0.4 ± 0.1 |
| Myo5p-SH3-AD | 398 ± 27 | |
| Myo3p-SH3-AD | 715 ± 125 | |
| Myo3p(SH3-W1157S)-AD | 0.3 ± 0.1 | |
| Myo3p-SH3 | 1,765 ± 209 | |
| Myo3p-AD | 0.4 ± 0.1 | |
| Vrp1p (1-200) | 0.3 ± 0.1 | |
| Vrp1p (195-817) | 144 ± 3 | |
| Bee1p (1-165) | Vector | 0.1 ± 0.1 |
| Myo3p-SH3-AD | 1,201 ± 117 | |
| Vrp1p (1-200) | 0.1 ± 0.1 | |
| Vrp1p (195-817) | 144 ± 10 | |
| Bee1p (166-633) | Vector | 0.4 ± 0.1 |
| Myo3p-SH3-AD | 113 ± 12 | |
| Vrp1p (1-200) | 0.4 ± 0.1 | |
| Vrp1p (195-817) | 0.5 ± 0.1 | |
| Vrp1p (1-817) | Vector | 0.1 ± 0.1 |
| Myo5p-SH3-AD | 373 ± 9 | |
| Myo3p-SH3-AD | 2,252 ± 194 | |
| Myo3p(SH3-W1157S)-AD | 0.1 ± 0.1 | |
| Myo3p-SH3 | 766 ± 94 | |
| Myo3p-AD | 0.1 ± 0.1 |
Assays were done as described (see Materials and Methods); pJG4-5 was the vector control. Full-length Bee1p (1-633), full-length Vrp1p (1-817), and NH2- and COOH-terminal fragments were analyzed.
Two-Hybrid Interactions between Proline-rich Peptides and the COOH-terminal Tails of Myo3p and Myo5p
| DNA-binding domain fusion | Activation-domain fusion | LacZ expression(Miller units) |
|---|---|---|
| QPDHPPPSPP (PRP1) | Vector | 0.2 ± 0.1 |
| Myo5p-SH3-AD | 406 ± 33 | |
| Myo3p-SH3-AD | 225 ± 8 | |
| Myo3p(SH3-W1157S)-AD | 0.2 ± 0.1 | |
| PPPYQAPHPP (PRP2) | Vector | 0.2 ± 0.1 |
| Myo5p-SH3-AD | 255 ± 31 | |
| Myo3p-SH3-AD | 210 ± 10 | |
| Myo3p(SH3-W1157S)-AD | 0.2 ± 0.1 | |
| NKPLPPLPVA (PBS2) | Vector | 0.3 ± 0.1 |
| Myo5p-SH3-AD | 0.2 ± 0.1 | |
| Myo3p-SH3-AD | 0.3 ± 0.1 | |
| Sho1p-SH3 | 190 ± 28 | |
| PPPYQAPH | Vector | 0 .3 ± 0.1 |
| Myo3p-SH3-AD | 219 ± 20 | |
| P | Vector | 0.2 ± 0.1 |
| Myo3p-SH3-AD | 0.3 ± 0.1 | |
| PPPYQA | Vector | 0.2 ± 0.1 |
| Myo3p-SH3-AD | 0.3 ± 0.1 | |
| PPPYQAPHP | Vector | 0.2 ± 0.1 |
| Myo3p-SH3-AD | 2.8 ± 0.4 |
Assays were done as described (see Materials and Methods); pJG4-5 was the vector control. For PRP2 derivatives, the proline substitution is indicated as a bold character.
Figure 5Model for the role of yeast myosin-I in Vrp1p-Bee1p-Arp2/3 mediated actin assembly. The Myo3/5p SH3 domain (circle) binds to Vrp1p and Bee1p. Myo3/5p and Bee1p bind and stimulate the nucleating activity of the Arp2/3 complex through their COOH-terminal acidic domains (arrow). The WH2 domains of Bee1p and Vrp1p bind and couple actin monomers to the Arp2/3 complex for efficient actin nucleation. To represent the WH2 domains, actin monomers are shown bound to Bee1p and Vrp1p. The interaction of the Arp2/3 complex with the regulatory acidic domains of Myo3p, Myo5p, and Bee1p is expected to be transient. Activation of the Arp2/3 complex leads to its incorporation into the actin cytoskeleton, either as a cap on the pointed end of an actin filament or attached to the side of a filament, creating cross-links and branches. The head domain of myosin-I (oval) may organize the newly formed filaments, displace filaments to facilitate barbed-ended insertion, or transport the Vrp1p-Bee1p-Arp2/3 actin assembly complex to the barbed end of a growing actin filament.